Hot Features
プレミアム
Revolution Medicines Inc (RVMD)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Anthony ManciniChief Global Commercialization Officer | -3.12k | 375.68k | Derivative Exercise and Sale | 33.62 - 154.82 | 54.40k | - |
| 2026-04-27 | Mr. Anthony ManciniChief Global Commercialization Officer | -3.12k | 308.23k | Derivative Exercise and Sale | 33.62 - 134.34 | 54.40k | - |
| 2026-04-15 | Dr. Mark A. GoldsmithCEO, President & Chairman | -120.00k | 17.46M | Derivative Exercise and Sale | 4.09 - 150.09 | 798.46k | - |
| 2026-03-25 | Mr. Anthony ManciniChief Global Commercialization Officer | -37.45k | 2.32M | Derivative Exercise and Sale | 33.62 - 97.21 | 54.40k | - |
| 2026-03-17 | Dr. Wei LinChief Medical Officer | -2.07k | 206.22k | Automatic Disposition | 99.48 | 39.32k | -5.01% |
| 2026-03-17 | Dr. Stephen M. KelseyPresident of Research & Development | -4.30k | 427.96k | Automatic Disposition | 99.48 | 211.15k | -2.00% |
| 2026-03-17 | Dr. Mark A. GoldsmithCEO, President & Chairman | -12.87k | 1.28M | Automatic Disposition | 99.48 | 798.46k | -1.59% |
| 2026-03-17 | Ms. Margaret A. HornCOO | -4.58k | 455.92k | Automatic Disposition | 99.48 | 84.52k | -5.14% |
| 2026-03-17 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -2.96k | 291.89k | Automatic Disposition | 97.44 - 99.48 | 10.39k | -22.16% |
| 2026-03-17 | Mr. Jack AndersCFO | -2.75k | 273.87k | Automatic Disposition | 99.48 | 68.91k | -3.84% |
| 2026-03-17 | Ms. Xiaolin WangExec. VP of Development | -2.01k | 199.96k | Automatic Disposition | 99.48 | 67.36k | -2.90% |
| 2026-03-04 | Ms. Elizabeth McKee AndersonIndependent Director | -15.00k | 0.00 | Other Disposition | - | 47.06k | -24.17% |
| 2026-03-02 | Dr. Mark A. GoldsmithCEO, President & Chairman | -30.00k | 2.91M | Derivative Exercise and Sale | 4.09 - 102.20 | 786.61k | - |
| 2026-03-02 | Dr. Mark A. GoldsmithCEO, President & Chairman | -6.00k | 607.78k | 売り | 98.29 - 102.08 | 786.61k | -0.76% |
| 2026-02-06 | Dr. Mark A. GoldsmithCEO, President & Chairman | 24.01k | 12.97k | Derivative Exercise and Retained Stock | 0.54 | 792.61k | 3.12% |
| 2026-01-21 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -908.00 | 104.96k | Automatic Disposition | 115.60 | 8.21k | -9.96% |
| 2026-01-07 | Ms. Margaret A. HornCOO | -75.00k | 4.66M | Derivative Exercise and Sale | 29.80 - 102.90 | 79.83k | - |
| 2026-01-07 | Mr. Jack AndersCFO | -10.00k | 555.50k | Derivative Exercise and Sale | 42.45 - 98.00 | 65.73k | - |
| 2025-12-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -2.69k | 206.48k | Automatic Disposition | 76.82 | 9.12k | -22.77% |
| 2025-12-16 | Dr. Stephen M. KelseyPresident of Research & Development | -5.45k | 418.42k | Automatic Disposition | 76.82 | 205.02k | -2.59% |
| 2025-12-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -15.39k | 1.18M | Automatic Disposition | 76.82 | 768.60k | -1.96% |
| 2025-12-16 | Ms. Margaret A. HornCOO | -4.85k | 372.33k | Automatic Disposition | 76.82 | 79.83k | -5.72% |
| 2025-12-16 | Mr. Jack AndersCFO | -3.10k | 239.29k | Automatic Disposition | 77.09 | 65.73k | -4.51% |
| 2025-11-25 | Dr. Mark A. GoldsmithCEO, President & Chairman | -60.00k | 4.26M | Derivative Exercise and Sale | 4.09 - 75.08 | 759.29k | - |
| 2025-11-25 | Dr. Mark A. GoldsmithCEO, President & Chairman | -6.00k | 450.00k | 売り | 75.00 | 759.29k | -0.78% |
| 2025-11-25 | Mr. Jack AndersCFO | -5.42k | 308.83k | Derivative Exercise and Sale | 17.00 - 74.00 | 62.72k | - |
| 2025-11-18 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -13.39k | 370.69k | Derivative Exercise and Sale | 42.45 - 70.14 | 6.52k | - |
| 2025-11-18 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20.00k | 1.33M | Derivative Exercise and Sale | 4.09 - 70.38 | 765.29k | - |
| 2025-11-12 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20.00k | 1.22M | Derivative Exercise and Sale | 4.09 - 65.07 | 765.29k | - |
| 2025-11-11 | Mr. Jack AndersCFO | -10.00k | 470.00k | Derivative Exercise and Sale | 17.00 - 64.00 | 62.72k | - |
| 2025-11-07 | Dr. Mark A. GoldsmithCEO, President & Chairman | -30.00k | 1.77M | Derivative Exercise and Sale | 1.12 - 60.31 | 765.29k | - |
| 2025-11-12 | Dr. Mark A. GoldsmithCEO, President & Chairman | -100.00k | 0.00 | Other Disposition | - | 765.29k | -11.56% |
| 2025-10-17 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -12.00k | 221.16k | Derivative Exercise and Sale | 36.57 - 55.00 | 6.52k | - |
| 2025-10-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20.00k | 1.03M | Derivative Exercise and Sale | 1.12 - 55.00 | 765.29k | - |
| 2025-10-13 | Dr. Stephen M. KelseyPresident of Research & Development | -25.00k | 1.10M | Derivative Exercise and Sale | 4.73 - 48.54 | 200.05k | - |
| 2025-09-24 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1.80k | 79.62k | Automatic Disposition | 44.26 | 6.52k | -21.64% |
| 2025-09-16 | Dr. Wei LinChief Medical Officer | -2.16k | 98.98k | Automatic Disposition | 45.82 | 29.49k | -6.82% |
| 2025-09-16 | Dr. Stephen M. KelseyPresident of Research & Development | -5.37k | 245.94k | Automatic Disposition | 45.82 | 200.05k | -2.61% |
| 2025-09-16 | Ms. Margaret A. HornCOO | -4.78k | 218.81k | Automatic Disposition | 45.82 | 75.40k | -5.96% |
| 2025-09-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -13.41k | 614.56k | Automatic Disposition | 45.82 | 765.29k | -1.72% |
| 2025-09-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1.87k | 85.65k | Automatic Disposition | 45.82 | 8.31k | -18.35% |
| 2025-09-16 | Mr. Jack AndersCFO | -2.32k | 106.31k | Automatic Disposition | 45.82 | 62.72k | -3.57% |
| 2025-09-11 | Dr. Stephen M. KelseyPresident of Research & Development | -125.00k | 4.97M | Derivative Exercise and Sale | 4.73 - 46.93 | 194.99k | - |
| 2025-09-02 | Mr. Jack AndersCFO | -10.00k | 334.32k | Derivative Exercise and Sale | 2.68 - 40.17 | 59.10k | - |
| 2025-06-30 | Dr. Mark A. GoldsmithCEO, President & Chairman | 37.00k | 19.98k | Derivative Exercise and Retained Stock | 0.54 | 753.98k | 5.16% |
| 2025-06-20 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1.91k | 75.74k | Automatic Disposition | 39.61 | 5.04k | -27.51% |
| 2025-06-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -13.50k | 537.55k | Automatic Disposition | 39.83 | 716.98k | -1.85% |
| 2025-06-16 | Ms. Margaret A. HornCOO | -3.51k | 139.80k | Automatic Disposition | 39.83 | 70.90k | -4.72% |
| 2025-06-16 | Mr. Jack AndersCFO | -2.17k | 86.43k | Automatic Disposition | 39.83 | 59.10k | -3.54% |
| 2025-06-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1.88k | 74.80k | Automatic Disposition | 39.83 | 6.95k | -21.27% |
| 2025-06-16 | Dr. Wei LinChief Medical Officer | -2.17k | 86.55k | Automatic Disposition | 39.83 | 25.70k | -7.80% |
| 2025-06-16 | Dr. Stephen M. KelseyPresident of Research & Development | -4.29k | 170.83k | Automatic Disposition | 39.83 | 194.99k | -2.15% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
